A Case Control Study of the Effectiveness of Q/LAIV Versus Inactivated Influenza Vaccine and No Vaccine in Subjects 2-17 Years of Age
Phase of Trial: Phase IV
Latest Information Update: 10 Apr 2017
At a glance
- Drugs MEDI 3250 (Primary) ; Influenza virus vaccine
- Indications Influenza virus infections
- Focus Therapeutic Use
- Acronyms ICICLE
- Sponsors MedImmune
- 10 Apr 2017 Results (n=1696) published in the Vaccine.
- 06 Sep 2016 Results of post-hoc analysis investigating the association between the lack of LAIV effectiveness against H1N1pdm09 strains and vaccine lot handling conditions during distribution published in the Vaccine.
- 06 Sep 2016 Planned End Date changed from 1 Jun 2017 to 1 Apr 2018.